AMLX - Amylyx Pharmaceuticals, Inc.

QQQ $ 496.90 $ 1.33 (0.27 %)

DIA $ 402.52 $ 2.04 (0.51 %)

SPY $ 561.53 $ 1.54 (0.28 %)

TLT $ 92.88 $ -1.08 (-1.15 %)

GLD $ 223.86 $ 0.72 (0.32 %)

Previous Close

$ 2.16

Open

$ 2.18

Bid

$ 2.16 x 2,598

Ask

$ 2.17 x 2,700

Day's Range

$ 2.16 - $ 2.30

52 Week Range

$ 1.58 - $ 25.48

Volume

2,358,273

Average Volume

Market Cap

146.57M

Beta (5Y Monthly)

$ 0.90

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-13-2023	12-31-2022	10-K
7	11-10-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-31-2022	12-31-2021	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Analyst Ratings For Amylyx Pharma
07/12/2024 19:01:19

nvidia-to-rally-more-than-33-here-are-10-top-analyst-forecasts-for-friday

NVIDIA To Rally More Than 33%? Here Are 10...
07/12/2024 13:01:36

Goldman Sachs Maintains Neutral on Amylyx ...
07/12/2024 10:09:10

Goldman Sachs analyst Chris Shibutani maintains Amylyx Pharma (NASDAQ:AMLX) with a Neutral and raises the price target from ...

why-is-small-cap-amylyx-pharmaceuticals-stock-trading-higher-on-wednesday

Why Is Small Cap Amylyx Pharmaceuticals St...
07/10/2024 19:32:36

Amylyx Pharmaceuticals acquired avexitide from Eiger BioPharmaceuticals Inc. for $35.1 million. Avexitide, a GLP-1 receptor ant...

HC Wainwright & Co. Reiterates Buy on Amyl...
07/10/2024 17:25:58

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

Amylyx Pharmaceuticals Acquired Avexitide ...
07/10/2024 11:04:34

As part of the transaction, Amylyx assumed certain contractual obligations from Eiger, including a 3% royalty on future sales o...

Amylyx Pharmaceuticals To Host Conference ...
07/09/2024 20:33:05

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced that Amylyx' managem...

6 Analysts Assess Amylyx Pharma: What You ...
06/24/2024 12:00:23

HC Wainwright & Co. Reiterates Buy on Amyl...
06/24/2024 10:22:57

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

Mizuho Maintains Neutral on Amylyx Pharma,...
05/14/2024 10:47:43

Mizuho analyst Graig Suvannavejh maintains Amylyx Pharma (NASDAQ:AMLX) with a Neutral and lowers the price target from $4 to...

Breaking Down Amylyx Pharma: 9 Analysts Sh...
05/10/2024 18:01:12

HC Wainwright & Co. Reiterates Buy on Amyl...
05/10/2024 12:25:27

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

Amylyx Pharma Cash, Cash Equivalents And ...
05/09/2024 12:04:14

Amylyx Pharma Q1 2024 GAAP EPS $(1.75)May ...
05/09/2024 12:03:33

Baird Maintains Neutral on Amylyx Pharma, ...
04/11/2024 10:43:32

Baird analyst Joel Beatty maintains Amylyx Pharma (NASDAQ:AMLX) with a Neutral and lowers the price target from $4 to $3.

HC Wainwright & Co. Reiterates Buy on Amyl...
04/11/2024 10:29:38

HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $8 price target.

amylyx-pharmaceuticals-investigational-drug-shows-improved-pancreatic-function-in-patients-with-inherited-disorder

Amylyx Pharmaceuticals' Investigational Dr...
04/10/2024 17:14:44

Amylyx's AMX0035 data in treating Wolfram syndrome, with interim data indicating positive effects on diabetes progression, ...

Amylyx Pharmaceuticals Announces Interim D...
04/10/2024 13:02:32

- Interim analysis, including eight participants assessed at Week 24, demonstrated improvements in pancreatic function and glyc...

Amylyx Pharmaceuticals To Host Virtual Web...
04/08/2024 13:01:44

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced the Company will host a ...

Unveiling 6 Analyst Insights On Amylyx Pharma
04/08/2024 12:00:22

CLASS ACTION DEADLINES - JOIN NOW!

07/16/2024 Teladoc Health, Inc. (TDOC)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Cambium Networks Corporation (CMBM)

07/22/2024 Biogen Inc. (BIIB)

07/23/2024 Fastly, Inc. (FSLY)

07/29/2024 Enphase Energy, Inc. (ENPH)

07/30/2024 Rivian Automotive, Inc. (RIVN)

07/30/2024 Hertz Global Holdings, Inc. (HTZ)

08/02/2024 Humana Inc. (HUM)

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

AMLXAmylyx Pharmaceuticals, Inc.

Nasdaq amylyx.com

$ 2.16 $ 0.00 (0 %)

Monday, 15-Jul-2024 15:59:55 EDT